{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:10:12Z","timestamp":1780085412724,"version":"3.54.0"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2010,11,8]],"date-time":"2010-11-08T00:00:00Z","timestamp":1289174400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0015430","type":"journal-article","created":{"date-parts":[[2010,11,9]],"date-time":"2010-11-09T00:17:19Z","timestamp":1289261839000},"page":"e15430","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":39,"title":["A Novel Target of Action of Minocycline in NGF-Induced Neurite Outgrowth in PC12 Cells: Translation Initiation Factor eIF4AI"],"prefix":"10.1371","volume":"5","author":[{"given":"Kenji","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamaki","family":"Ishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,11,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tips.2004.10.001","article-title":"Neuroprotection by tetracyclines.","volume":"25","author":"M Domercq","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.nbd.2004.07.012","article-title":"Clinical potential of minocycline for neurodegenerative disorders.","volume":"17","author":"D Blum","year":"2004","journal-title":"Neurobiol Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2174\/1381612043453162","article-title":"Minocycline: neuroprotective mechanisms in Parkinson&apos;s disease.","volume":"10","author":"M Thomas","year":"2004","journal-title":"Curr Pharm Des"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2174\/187152708786441858","article-title":"Clinical potential of minocycline for schizophrenia.","volume":"7","author":"T Miyaoka","year":"2008","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2174\/187152709788680689","article-title":"Neuroprotective effects of tetracyclines: molecular targets, animal models and human disease.","volume":"8","author":"D Orsucci","year":"2009","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"13496","DOI":"10.1073\/pnas.96.23.13496","article-title":"A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window.","volume":"96","author":"J Yrj\u00e4nheikki","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/nbdi.2002.0487","article-title":"Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis.","volume":"10","author":"J Kriz","year":"2002","journal-title":"Neurobiol Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"14669","DOI":"10.1073\/pnas.251341998","article-title":"Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson&apos;s disease.","volume":"98","author":"Y Du","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"10483","DOI":"10.1073\/pnas.1832501100","article-title":"Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington&apos;s disease.","volume":"100","author":"X Wang","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e9793","DOI":"10.1371\/journal.pone.0009793","article-title":"Comprehensive behavioral testing in the R6\/2 mouse model of Huntington&apos;s disease shows no benefit from CoQ10 or minocycline.","volume":"5","author":"LB Menalled","year":"2010","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1073\/pnas.0306239101","article-title":"Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury.","volume":"101","author":"YD Teng","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1038\/sj.npp.1301377","article-title":"Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer&apos;s disease models.","volume":"32","author":"Y Choi","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e4151","DOI":"10.1371\/journal.pone.0004151","article-title":"PEG minocycline-liposomes ameliorate CNS autoimmune disease.","volume":"4","author":"W Hu","year":"2009","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.pnpbp.2006.05.015","article-title":"Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine.","volume":"30","author":"L Zhang","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1038\/sj.npp.1301313","article-title":"Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine.","volume":"32","author":"L Zhang","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.brainres.2007.03.080","article-title":"Minocycline, a second-generation tetracycline, as a neuroprotective agent in an animal model of schizophrenia.","volume":"1154","author":"Y Levkovitz","year":"2007","journal-title":"Brain Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.biopsych.2006.03.019","article-title":"Protective effects of minocycline on the reduction of dopamine transporters in the striatum after administration of methamphetamine: a positron emission tomography study in conscious monkeys.","volume":"61","author":"K Hashimoto","year":"2007","journal-title":"Biol Psychiatry"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.pnpbp.2007.08.031","article-title":"Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline.","volume":"32","author":"Y Fujita","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4088\/JCP.08m04666yel","article-title":"A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia.","volume":"71","author":"Y Levkovitz","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"ref20","article-title":"A case of methamphetamine use disorder treated with the antibiotic drug minocycline.","author":"Y Tanibuchi","year":"2010","journal-title":"Gen Hosp Psychiatry in press"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pbb.2008.11.004","article-title":"Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans.","volume":"92","author":"M Sofuoglu","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1086\/651277","article-title":"Minocycline attenuates HIV infection and reactivation by suppressing cellular activation in human CD4<sup>+<\/sup> T cells.","volume":"201","author":"GL Szeto","year":"2010","journal-title":"J Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e10523","DOI":"10.1371\/journal.pone.0010523","article-title":"Proton magnetic resonance spectroscopy reveals neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDS.","volume":"5","author":"EM Ratai","year":"2010","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e2558","DOI":"10.1371\/journal.pone.0002558","article-title":"Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways.","volume":"3","author":"T Nishimura","year":"2008","journal-title":"PLoS ONE"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.pnpbp.2008.06.011","article-title":"Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by donepezil: role of sigma-1 receptors and IP<sub>3<\/sub> receptors.","volume":"32","author":"T Ishima","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev.biochem.72.121801.161629","article-title":"Trk receptors: roles in neuronal signal transduction.","volume":"72","author":"EJ Huang","year":"2001","journal-title":"Annu Rev Biochem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrn1078","article-title":"Neurotrophins and their receptors: a convergence point for many signaling pathways.","volume":"4","author":"MV Chao","year":"2003","journal-title":"Nature Rev Neurosci"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1007\/s00018-009-0057-8","article-title":"Involvement of Akt in neurite outgrowth.","volume":"66","author":"DE Read","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0896-6273(00)80384-0","article-title":"Xestospongins: potent membrane permeable blockers of the inositol 1,4,5-trisphosphate receptor.","volume":"19","author":"J Gafni","year":"1997","journal-title":"Neuron"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"9685","DOI":"10.1073\/pnas.0600554103","article-title":"Minocycline inhibits poly (ADP-ribose) polymerase-1 at nanomolar concentrations.","volume":"103","author":"CC Alano","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainres.2006.02.042","article-title":"Minocycline protects PC12 cells against NMDA-induced injury via inhibiting 5-lipoxygenase activation.","volume":"1085","author":"Y Song","year":"2006","journal-title":"Brain Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0079-6603(02)72073-4","article-title":"eIF4A: the godfather of the DEAD box helicases.","volume":"72","author":"GW Rogers Jr","year":"2002","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.biochem.73.030403.080419","article-title":"The molecular mechanisms of eukaryotic translation.","volume":"73","author":"LD Kapp","year":"2004","journal-title":"Annu Rev Biochem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.mod.2005.04.002","article-title":"Functional diversity of the eukaryotic translation initiation factors belonging to eIF4 families.","volume":"122","author":"G Hern\u00e1ndez","year":"2005","journal-title":"Mech Dev"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1146\/annurev.neuro.24.1.1217","article-title":"Nerve growth factor signaling, neuroprotection, and neural repair.","volume":"24","author":"MV Sofroniew","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0896-6273(94)90223-2","article-title":"Trk receptors use redundant signal transduction pathways involving SHC and PLC-gamma 1 to mediate NGF responses.","volume":"12","author":"RM Stephens","year":"1994","journal-title":"Neuron"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"18961","DOI":"10.1016\/S0021-9258(17)32260-3","article-title":"Neurite outgrowth of PC12 cells is suppressed by wortmannin, a specific inhibitor of phosphatidylinositol 3-kinase.","volume":"269","author":"K Kimura","year":"1994","journal-title":"J Biol Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuron.2008.10.055","article-title":"Translational control of long-lasting synaptic plasticity and memory.","volume":"61","author":"M Costa-Mattioli","year":"2009","journal-title":"Neuron"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients.","volume":"47","author":"RM Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.","volume":"63","author":"CA Zarate Jr","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrd2462","article-title":"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders.","volume":"7","author":"G Sanacora","year":"2008","journal-title":"Nature Rev Drug Discov"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.brainresrev.2009.05.005","article-title":"Emerging role of glutamate in the pathophysiology of major depressive disorder.","volume":"61","author":"K Hashimoto","year":"2009","journal-title":"Brain Res Rev"},{"key":"ref43","article-title":"The role of glutamate on the action of antidepressants.","author":"K Hashimoto","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry in press"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.","volume":"329","author":"N Li","year":"2010","journal-title":"Science"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.cellsig.2007.11.015","article-title":"Roles of autophagy and mTOR signaling in neuronal differentiation of mouse neuroblastoma cells.","volume":"20","author":"M Zeng","year":"2008","journal-title":"Cell Signal"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.tins.2009.11.003","article-title":"mTOR signaling: At the crossroads of plasticity, memory and disease.","volume":"33","author":"CA Hoeffer","year":"2009","journal-title":"Trends Neurosci"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1176\/ajp.153.4.582b","article-title":"Possible antidepressant effect of minocycline.","volume":"153","author":"J Levine","year":"1996","journal-title":"Am J Psychiatry"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.biopha.2007.12.005","article-title":"Does minocycline have antidepressant effect?","volume":"62","author":"CU Pae","year":"2008","journal-title":"Biomed Pharmacother"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tcb.2004.04.006","article-title":"Guiding neuronal growth cones using Ca<sup>2+<\/sup> signals.","volume":"14","author":"J Henley","year":"2004","journal-title":"Trends Cell Biol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ceca.2005.01.007","article-title":"Calcium signaling in growth cone migration.","volume":"37","author":"SR Blosover","year":"2005","journal-title":"Cell Calcium"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1126\/science.282.5394.1705","article-title":"Regulation of nerve growth mediated by inositol 1,4,5-trisphosphate receptors in growth cones.","volume":"282","author":"K Takei","year":"1998","journal-title":"Science"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejphar.2010.09.007","article-title":"Potentiation of nerve growth factor-induced neurite outgrowth by the ROCK inhibitor Y-27632: a possible role of IP<sub>3<\/sub> receptors.","volume":"648","author":"T Minase","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nrm2838","article-title":"The mechanism of eukaryotic translation initiation and principles of its regulation.","volume":"10","author":"RJ Jackson","year":"2010","journal-title":"Nature Rev Mol Cell Biol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.molcel.2009.11.013","article-title":"The ELAV protein HuD stimulates cap-dependent translation in a Poly(A)- and eIF4A-dependent manner.","volume":"36","author":"A Fukao","year":"2009","journal-title":"Mol Cell"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.molcel.2009.12.013","article-title":"HuD stimulates translation via eIF4A.","volume":"36","author":"CY Chen","year":"2009","journal-title":"Mol Cell"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.cell.2009.01.042","article-title":"Regulation of translation initiation in eukaryotes: mechanisms and biological targets.","volume":"136","author":"N Sonenberg","year":"2009","journal-title":"Cell"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tibs.2003.11.006","article-title":"Translation factors: in sickness and in health.","volume":"29","author":"AM Abbott","year":"2004","journal-title":"Trends Biochem Sci"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrg2142","article-title":"Translation matters: protein synthesis defects in inherited disease.","volume":"8","author":"GC Scheper","year":"2007","journal-title":"Nature Rev Genet"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2990.2002.t01-1-00410.x","article-title":"Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer&apos;s disease and Creutzfeldt-Jakob&apos;s disease.","volume":"28","author":"I Ferrer","year":"2002","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/NEN.0b013e3181aed9e6","article-title":"Amyloid b-induced nerve growth factor dysmetabolism in Alzheimer disease.","volume":"68","author":"MA Bruno","year":"2009","journal-title":"J Neuropathol Exp Neurol"}],"updated-by":[{"DOI":"10.1371\/annotation\/afc0a9a2-01c0-4e58-8d69-e0ed4ff953fa","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2010,12,3]],"date-time":"2010-12-03T00:00:00Z","timestamp":1291334400000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0015430","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T07:13:36Z","timestamp":1636787616000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0015430"}},"subtitle":[],"editor":[{"given":"Tadafumi","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,11,8]]},"references-count":60,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2010,11,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0015430","relation":{"correction":[{"id-type":"doi","id":"10.1371\/annotation\/afc0a9a2-01c0-4e58-8d69-e0ed4ff953fa","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,8]]}}}